Medical Training AIPrescribing Digital Therapeutics
You'll be able to evaluate, select, and monitor FDA-cleared digital therapeutics for appropriate mental health patients.
What this track covers
This track covers the regulatory basis for prescription digital therapeutics and the clinical evidence behind FDA-cleared platforms for conditions like substance use disorder, insomnia, and ADHD. It focuses on matching patients to appropriate digital interventions, integrating them into existing treatment plans, and tracking engagement and outcomes over time.
What you will practice
- Distinguish FDA clearance pathways and what they do and don't establish about a digital therapeutic
- Match patient presentation and history to an appropriate FDA-cleared platform
- Identify contraindications or situations where a digital intervention is not appropriate
- Integrate a digital therapeutic into an existing treatment plan and follow-up schedule
- Interpret engagement and adherence data to decide whether to continue, adjust, or discontinue
Simulator scenario
A patient with insomnia and comorbid anxiety returns for follow-up after starting a digital therapeutic, presenting with inconsistent app engagement, and the clinician must decide whether to continue, modify, or discontinue the intervention.
Board question topics
- FDA regulatory pathways for digital therapeutics
- patient selection and contraindications
- monitoring engagement and adherence
- integrating digital interventions with existing care plans
Ask the tutor
The tutor only answers from licensed sources (FDA prescribing information, public guidelines and our own material) and says when it has none. Educational use only, never patient-specific advice.
Free during the beta. Sign in with your email, no password.
Start free